Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-011603
Filing Date
2024-08-08
Accepted
2024-08-08 16:13:52
Documents
63
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mist-20240630x10q.htm   iXBRL 10-Q 1534632
2 EX-31.1 mist-20240630xex31d1.htm EX-31.1 12313
3 EX-31.2 mist-20240630xex31d2.htm EX-31.2 12464
4 EX-32.1 mist-20240630xex32d1.htm EX-32.1 9433
  Complete submission text file 0001558370-24-011603.txt   6449409

Data Files

Seq Description Document Type Size
5 EX-101.SCH mist-20240630.xsd EX-101.SCH 42282
6 EX-101.CAL mist-20240630_cal.xml EX-101.CAL 39705
7 EX-101.DEF mist-20240630_def.xml EX-101.DEF 168948
8 EX-101.LAB mist-20240630_lab.xml EX-101.LAB 358564
9 EX-101.PRE mist-20240630_pre.xml EX-101.PRE 284785
66 EXTRACTED XBRL INSTANCE DOCUMENT mist-20240630x10q_htm.xml XML 1227359
Mailing Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6
Business Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Filer) CIK: 0001408443 (see all company filings)

EIN.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38899 | Film No.: 241188502
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)